BeOne Medicines ONC
NASDAQ ONC
$358.06 -4.62 (-1.27%)
As of: Sep 4, 2026 · 3:14 PM EDT

BeOne Medicines (ONC) Operating Margin (QoQ) (2015 - 2026)

Analysis

BeOne Medicines (ONC) Operating Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 255.00
Mar 31, 2026 416.00
Dec 31, 2025 80.00
Sep 30, 2025 487.00
Jun 30, 2025 569.00
Mar 31, 2025 804.00
Dec 31, 2024 496.00
Sep 30, 2024 -47.00
Jun 30, 2024 2,324.00
Mar 31, 2024 2,573.00
Dec 31, 2023 -4,335.00
Sep 30, 2023 3,640.00
Jun 30, 2023 2,936.00
Mar 31, 2023 4,038.00
Dec 31, 2022 -1,020.00
Sep 30, 2022 1,555.00
Jun 30, 2022 1,593.00
Mar 31, 2022 12,262.00
Dec 31, 2021 -4,324.00
Sep 30, 2021 9,262.00